• Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management

    Join us March 13-15, 2026, for the virtual Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management. Led by Program Chair, Saurabh Malhotra, MD, MPH, FASNC, Masterclass features multidisciplinary content that today’s practitioners need to keep current in the rapidly advancing field of cardiac amyloidosis. Masterclass will cover: the pathogenesis of cardiac amyloidosis; diagnostic techniques and […]

  • ICA 2026: 20. International Conference on Amyloidosis

    The International Research Conference Aims and Objectives The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, […]

  • Kongres EHA2026

    W dniach 11-14 czerwca 2026 r. w Sztokholmie (Szwecja) odbędzie się Kongres EHA2026, który łączy globalną społeczność hematologów. W czasie wydarzenia zaprezentowane zostaną najnowsze aktualizacje kliniczne i badawcze w dziedzinie hematologii. Ponadto udział w Kongresie jest szansą na nawiązanie kontaktu z wiodącymi ekspertami i poznanie najnowszych osiągnięć w hematologii. Ważne daty: 1 marca 2026 r. - termin składania streszczeń, […]

  • ESC Congress 2026

    Be part of ESC Congress 2026, the world’s foremost cardiology meeting, where transformation moves from promise to practice. This year’s Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot, enhancing precision, speed, and safety in patient care. Discover AI in action, from diagnosis to delivery, through hands-on sessions, live demonstrations, and immersive learning. Here, every subspecialty […]

  • Young Baltic Cardio 2026

    Victoria Hotel Klaipėda, S. Šimkaus g. 2, LT-92128, Klaipėda, Lithuania

    The first Young Baltic Cardio Conference will bring together experts, researchers and clinicians from the Baltic countries and beyond to discuss recent advances in cardiology. The second day of the meeting will include an afternoon session dedicated to amyloidosis, with topics covering early detection of cardiac amyloidosis, TTR suppressors in clinical practice, multimodality imaging, prognostication, […]

  • Advances in the Diagnosis and Treatment of Amyloidosis in 2026

    NYU Langone Health, 550 First Ave New York, NY United States

    Advances in the Diagnosis and Treatment of Amyloidosis in 2026 is a course focused on advanced management of patients with TTR and light chain (AL) amyloidosis. Experts from multiple specialties will present recent developments in diagnosis and treatment, using real-world case scenarios to discuss the complexities of amyloidosis care. Detailed information and the registration form […]

  • 2026 Amyloidosis Forum Annual Meeting

    The 2026 Amyloidosis Forum Annual Meeting will bring together clinicians, researchers, FDA and global health authorities, industry partners, patients and the Amyloidosis Research Consortium. Participants will present the work of stakeholder groups focused on accelerating drug development in AL and ATTR amyloidosis. Detailed information are available on the event website.  

  • X Interdyscyplinarna Konferencja Amyloidoza

    Zapraszamy do udziału w X Interdyscyplinarnej Konferencji Amyloidoza, która odbędzie się w dniach 2-3 października 2026 r. w formule on-line. Celem Konferencji jest aktualizacja wiedzy na temat amyloidozy oraz wymiana doświadczeń pomiędzy lekarzami różnych specjalności medycznych. Mamy nadzieję, że Konferencja przyczyni się do poprawy diagnostyki i terapii amyloidozy w Polsce, a także stanie się impulsem do wspólnych […]

  • 2026 Global Cardio-Oncology Summit

    On behalf of the International Cardio-Oncology Society, it is our honor to invite you to join us for the 2026 Global Cardio-Oncology Summit (GC-OS), to be held from October 5-7, 2026, in Williamsburg, Virginia. GC-OS is the premier international, interdisciplinary event dedicated to advancing the prevention and management of cardiovascular disease among cancer survivors. Our […]

  • XX International Symposium on Amyloidosis – ISA 2026

    As Chair of the Program Committee, ISA Board member Eloisa Riva is collaborating with colleagues from the Latin American Program Committee and the international Scientific Committee to develop a comprehensive program to expand knowledge and foster meaningful connections across all disciplines in the amyloidosis community. In addition to cutting-edge scientific presentations, the committees are organizing […]